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many different causes, and it can be a primary cause of
illness (as in pneumonia or aspiration) or a secondary
failure as a general response to major stress (congestive
heart failure, sepsis, or hypotension).
Pneumonia and aspiration are the two most dangerous
causes of primary respiratory failure in patients under-
going lung resection. We believe that pneumonia devel-
ops in patients with poor pain control and weak cough,
whereas aspiration occurs in patients with impaired or
delayed gastrointestinal tract transit. Epidural catheters
clearly help treat pain but may contribute to ileus.
Further, we believe that recovery from aspiration after
lung resection is a long, tedious process and less gener-
ally successful than recovery from pneumonia.
Either primary or secondary failure can lead to adult
respiratory distress syndrome (ARDS). Although the
M any studies on perioperative mortality after lungresection and thoracotomy have concluded that
respiratory failure is the most common cause of
death.1,2 However, respiratory failure can result from
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survival after the development of ARDS has been
reported to be as low as 50%, anecdotal reports suggest
that the survival after the development of ARDS in the
setting of lung resection is less. Thus prevention of the
complication is paramount.
In response to two episodes of aspiration, the prima-
ry surgeon in this study (J.R.R.) changed his manage-
ment policy from an ad libitum dietary advancement to
one of routine gastric drainage perioperatively and
dietary control in hopes of decreasing the incidence of
aspiration.
Methods
All patients undergoing elective thoracotomy by a single
surgeon at several hospitals over 42 months were included in
the study. The study was limited to a single surgeon’s experi-
ence because the change in management was not consistent
with the management done by the other surgeons in the same
practice. All patients undergoing thoracotomy and resections
requiring lobectomy, complicated lobectomy (including chest
wall resections, diaphragm resections, sleeve resections of
artery or bronchus, and lobectomies in patients with a forced
expiratory volume in 1 second <1 L), decortication, or pneu-
monectomy were given epidural anesthesia and chest physio-
therapy and early ambulation. Patients were initially given
clear liquid diets and diet was advanced as tolerated after the
operation. Cathartics were given as necessary to promote
bowel activity. The remainder of gastrointestinal tract man-
agement was directed toward identifying ileus and treating it
when clinically manifest.
After two episodes of apparent aspiration in 1 week, gas-
trointestinal tract management was altered to diminish the
chance of aspiration. Nasogastric tubes were placed intraop-
eratively and removed in the recovery room if less than 300
mL of liquid was obtained during the operation. Dietary man-
agement was nothing by mouth the day of the operation, clear
liquids the first postoperative day, and regular diets the sec-
ond postoperative day. Nasogastric tubes were replaced after
any episode of vomiting, and performance of daily abdominal
examinations to identify ileus was stressed to the residency
and nursing staff. Fifty-four patients (36%) had nasogastric
tubes in place overnight. Fourteen patients (9%) required
replacement of nasogastric tubes because of abdominal dis-
tention or vomiting. If ileus was identified, a nothing by
mouth order was given and patients were followed up.
Data analyzed included age, sex, pulmonary function test
results, types of procedures, mortality, respiratory mortality,
morbidity, life-threatening complications, tracheostomy, and
reintubation. Patients were considered to have aspirated if
diffuse infiltrates developed or culture of the sputa grew mul-
tiple organisms. Patients were considered to have pneumonia
if they had infiltrates in one or two adjoining lobes and cul-
ture of the sputa grew a single dominant organism. Mortality
was defined as hospital mortality, regardless of whether this
occurred before or after 30 days. Life-threatening complica-
tions were defined as those that prompted intubation, car-
dioversion, or emergency operation or caused sepsis. Patients
underwent a variety of procedures, including lobectomies,
pneumonectomies, decortications, and complicated lobec-
tomies.
The Student t test was used to assess differences in means,
and the Fisher exact test was used to assess differences in
proportions. This was a comparison study of sequential
groups of patients. Because the event being studied is an
extremely low-frequency event, the usual adjustments for
nonrandomized trials that attempt to adjust for selection fac-
tors were powerless in this low-frequency setting.
Results
A total of 275 patients underwent thoracotomy, 124
before and 151 after the change in gastrointestinal tract
management. Table I lists the patients and their demo-
graphic analyses. No differences in proportion of men
and women, age, or pulmonary function were found.
Table II summarizes the proportions of procedures.
Differences in proportions of lobectomies and of
decortications were found, with relatively more lobec-
tomies in the second group and relatively more decor-
tications in the first.
Table III summarizes the mortality data. Four of 124
patients died before hospital discharge in the first
group. All of these patients died of respiratory causes
for an overall and respiratory mortality rate of 3.23%.
In the second group, 2 of 151 patients died (bowel
Table I. Patient demographics
Before 7/1/97 After 7/1/97 P value
No. of patients 124 151
Men 80 97 .96
Women 44 54
Age (y) 59 ± 14 60 ± 15 .86
Lobectomies 49 81
Complicated lobectomies 21 26
Pneumonectomies 18 17
Decortications 36 27 
Analysis of patient demographics revealed no significant difference between
the two procedures in fraction of men or in type of procedure.
Table II. Distribution of procedures
Before 7/1/97 After 7/1/97 P value
Lobectomies 49 (39.5%) 81 (53.6%) .02
Pneumonectomies 18 (14.5%) 17 (11.3%) .47
Neoadjuvant 13 (10.5%) 24 (15.9%) .03
Decortication 36 (29.0%) 27 (17.9%) .03
Complicated lobectomies 21 (17.0%) 26 (17.4%) .99
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ischemia, empyema) for an overall mortality rate of
1.23%. There were no respiratory deaths in the second
group, so that the respiratory mortality rate was 0.00%.
The difference in overall mortality was not significant,
whereas the difference in respiratory mortality was sig-
nificant (P = .04).
Respiratory morbidity is summarized in Table IV.
The incidence of aspiration as defined in this study was
entirely eliminated and represented a significant
change. No significant changes in pneumonia and rein-
tubation were found. Other factors were analyzed (inci-
dence of tracheostomy and of life-threatening compli-
cations) but did not reach statistical significance.
Discussion
A surgeon provides two primary services to a patient
with cancer: removing the tumor with disease-free
margins and getting the patient safely through the pro-
cedure. To that end, analyses of care patterns that can
improve the likelihood of safe operations get at the
heart of what cancer surgeons do.
Kohman and colleagues3 analyzed 37 different fac-
tors that might affect the morbidity and mortality of
lung resections and determined that preoperative fac-
tors only predict 28% of the risk in patients undergoing
lung resection. They concluded that 72% of the com-
plications must be attributed to factors not considered
or to random factors. Our data indicate that issues of
surgical management, specifically aspiration, might
account for a portion of, or can decrease the impact of,
these random factors.
Table V lists the largest series that report periopera-
tive mortality after lobectomy and pneumonectomy.
Mortality rates for lobectomy range from 0.47% in the
Brigham series8 to as high as 4.03%. The mortality rate
for pneumonectomies ranges from 6.2% to 11.7%.
Nesbitt and associates10 recently reported an 8% peri-
operative mortality rate for all pneumonectomies done
at the MD Anderson Cancer Center. These data all
demonstrate that lung resection, whether by lobectomy
or pneumonectomy, remains much more dangerous
than a first-time cardiac bypass.
Whereas all these studies evaluated preoperative risk
factors in attempts to predict mortality, no good infor-
mation identifies operative or perioperative management
that might affect mortality. Further, no attempt has been
made to separate the different causes of respiratory fail-
ure that might contribute to perioperative mortality.
Our data indicate that the chance of aspiration and the
frequency of respiratory mortality can be decreased
with gastrointestinal tract management that includes use
of nasogastric tubes, dietary management, and frequent
abdominal examinations. These are all techniques com-
mon to general surgical practice, and techniques that we
apply routinely now to general thoracic surgical prac-
tice. Certainly many patients can be safely treated with-
out such aggressive gastrointestinal tract management,
as the mortality risk in our patients before our change
indicates. However, the cost of a single aspiration, both
in dollar terms and in mortality terms, is so high that
significant measures to prevent it are justified.
We thank Richard R. Pierson, MD, for comments about the
manuscript and Debbie Poteet for manuscript preparation.
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Discussion
Dr Scott J. Swanson (Boston, Mass). Do you see any
downside to using the nasogastric tube during the first couple
of days, and could that be contributing to why you might be
seeing more cases of pneumonia?
Dr Roberts. I am not entirely sure now what the best tim-
ing is for the use of the nasogastric tube. Currently I put it in
in the operating room and then take it out the night of the
operation if the drainage has not been greater than 300 mL.
As you know, a nasogastric tube will decrease the patient’s
ability to cough, and it is certainly possible that the tube is
contributing to pneumonia.
Dr Swanson. What size nasogastric tube were you using?
Was it variable?
Dr Roberts. Variable, yes.
Dr Swanson. Do you think you would get the same bene-
fit with a small tube but also potentially allow better clearance
of secretions, or do you think function of the nasogastric tube
would be a problem if it was too small?
Dr Roberts. That is a good suggestion. In some sense I
think of the tube as a diagnostic maneuver rather than a ther-
apeutic maneuver, at least initially, to find out if there are a lot
of gastric contents. It may very well be that a small tube
would be as useful as inserting the tube in the operating room
and taking it out if there is not much drainage.
Dr Valerie W. Rusch (New York, NY). Can you tell us some-
thing about the type of epidural analgesia used? Were only
narcotics used? Do your anesthesiologists use narcotics plus a
local anesthetic? Is there a uniform policy in that regard?
Dr Roberts. We use a thoracic epidural that is a combina-
tion of narcotics and local anesthetic. We typically vary it a
little bit after it is in place if we have trouble with hypoten-
sion and decrease the amount of local anesthetic. By and
large, however, it is pretty standard.
Dr Rusch. That may have some impact on the severity or
duration of the ileus. Also, how many patients were actively
smoking when they were admitted for the operation?
Dr Roberts. I do not have any data on that.
Dr Rusch. That really could be a confounding factor with
respect to the frequency of postoperative respiratory problems.
Dr Roberts. Yes, I think it especially has an impact con-
cerning pneumonia. Whereas I do not do volume-reduction
operations in patients who are actively smoking, I do do lung
cancer operations in patients who are still smoking; however,
I do not have data on that.
Dr Mark K. Ferguson (Chicago, Ill). You are postulating
that the epidural anesthetic contributes to the ileus. Are you
leaving the epidural in until the chest tubes are removed?
Dr Roberts. Variably. Typically we leave the epidural in
about 4 to 5 days if there is still an air leak, and then we usu-
ally take it out.
Dr Ferguson. I am curious as to how you think the naso-
gastric tube contributes if it is only left in overnight.
Dr Roberts. Overnight is the standard amount of time. If
there is greater than 300 mL of fluid, then it is left in place.
Several patients had them in for 4 or 5 days before the diet
was advanced. In some sense, as I said, this is a diagnostic
maneuver to determine whether the patients are having ileus
in response to the operation and the epidural. If there is a lot
of drainage at the end of the first day, then the tube stays in.
Dr Wickii T. Vigneswaran (Chicago, Ill). Can you com-
ment about fluid management perioperatively? Did you
change your management in any way? Did you actively use a
vasoconstrictor because of the use of the epidural, which may
have contributed to the bowel ischemia in one of the patients?
Dr Roberts. The one episode of bowel ischemia occurred
on postoperative day 5 in an 80-year-old patient we were get-
ting ready to send home, and I think his epidural had been out
for a couple of days. I do not give patients any unneeded fluid.
We do use dopamine and low-dose phenylephrine hydrochlo-
ride (Neo-Synephrine) for the immediate perioperative period,
but the phenylephrine hydrochloride is always discontinued
before they leave the recovery room later that day. 
Dr Ferguson. Given some of the issues that have been
raised and the potential importance of this, do you think a ran-
domized trial is indicated, or are you sufficiently convinced?
Dr Roberts. At this point I am pretty convinced of the
importance of it, and I have not considered whether a ran-
domized trial would be appropriate. I have considered, from
the standpoint of extending the data, doing a study to evalu-
ate how bowel function is affected by epidurals, because
when I talk to my anesthesia colleagues about whether there
is a chance that patients really get an ileus from an epidural,
they all say that that is not possible. For me, at least, this has
been fairly convincing, and for the time being I have not con-
sidered a randomized trial.
